Skip to content

Clinical trail of HANZ to evaluate the efficacy and safety.

Exploratory clinical trail of HANZ to evaluate the efficacy and safety.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2052200091
Enrollment
33
Registered
2020-12-04
Start date
2021-01-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel surgery due to carpal tunnel syndrome. Nerve suturing due to finger nerve rupture.

Interventions

In carpal tunnel surgery, HANZ01 is partially covered or wrapped around the peripheral nerve that has opened the nerve strangulation site. In nerve suturing, HANZ01 is wrapped around the peripheral ne

Sponsors

TANAKA Hiroyuki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (Carpal tunnel surgery) 1) Patients with a terminal latency (TL) of 6 ms or more before surgery. 2) Patients with a compound muscle action potential (CMAP) of 0.3 mV or more before surgery. (Nerve suture) 1) Patients who do not have multiple nerve ruptures and require only one finger nerve suture.

Exclusion criteria

Exclusion criteria: (Carpal tunnel surgery) 1) Patients with a history of carpal tunnel surgery in the same hand. 2) Patients with diabetes or cervical spine lesions. 3) Patients receiving dialysis treatment. 4) Pregnant women, patients who may be pregnant, breast-feeding patients, and patients who wish to become pregnant during the clinical trial period. (Nerve suture) 1) Patient who have fractures on target fingers that require nerve suture. 2) Patients who have damaged finger pulp where it is difficult to measure sensory function evaluation (SW test or two-point discrimination). 3) Patients who need surgery other than finger nerve suture at the same time. 4) Patients who need nerve regeneration inducer. 5) Patients with diabetes or cervical spine lesions. 6) Patients receiving dialysis treatment. 7) Pregnant women, patients who may be pregnant, breast-feeding patients and patients who wish to become pregnant during the clinical trial period.

Design outcomes

Primary

MeasureTime frame
Efficacy (Carpal tunnel surgery) Change from baseline in terminal latency (TL). (Nerve suture) Change from baseline in SW test and two-point discrimination. Safety (Carpal tunnel surgery, Nerve suture) Device Deficiencies, adverse events.

Contacts

Public ContactI Development

Nippon Zoki Pharmaceutical Co.,LTD

clindev-md@nippon-zoki.co.jp+81-6-6203-0455

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026